ATC codes:
H02AB04
EMLc
Indication
Lymphoid leukaemia, not elsewhere classified
ICD11 code:
2B33.3
INN
Methylprednisolone
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
40 mg in vial (as sodium succinate) powder for injection
(EMLc)
;
125 mg in vial (as sodium succinate) powder for injection
(EMLc)
EML status history
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of methylprednisolone 125 mg powder for injection to the EMLc;
- the deletion of methylprednisolone injection 80 mg/mL from the EMLc;
- update the description of methylprednisolone 40 mg injection (powder for injection in vial).